http://www.legislation.gov.uk/eudn/2011/862/article/8/adoptedCommission Implementing Decision of 19 December 2011 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2011) 9478) (2011/862/EU)Commission Implementing Decision of 19 December 2011 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2011) 9478) (2011/862/EU)2020-12-11King's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011D0862texttext/xmlen Amendments to Decision 2010/712/EU Article 8 Decision 2010/712/EU is amended as follows: Article 1 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 4 600 000 for Spain; EUR 3 000 000 for Italy; EUR 90 000 for Cyprus; EUR 1 040 000 for Portugal; EUR 1 350 000 for the United Kingdom. ; in paragraph 3, points (a) to (d) are replaced by the following: (a) for a rose bengal test EUR 0,24 per test; (b) for a SAT test EUR 0,24 per test; (c) for a complement fixation test EUR 0,48 per test; (d) for an ELISA test EUR 1,2 per test ; Article 2 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 16 000 000 for Ireland; EUR 18 500 000 for Spain; EUR 5 500 000 for Italy; EUR 1 440 000 for Portugal; EUR 26 500 000 for the United Kingdom. ; in paragraph 3, points (a) and (b) are replaced by the following: (a) for a tuberculin test EUR 2,4 per test; (b) for a gamma-interferon test EUR 6 per test ; Article 3 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 160 000 for Greece; EUR 9 200 000 for Spain; EUR 4 200 000 for Italy; EUR 85 000 for Cyprus; EUR 2 260 000 for Portugal. ; in paragraph 3, points (a) and (b) are replaced by the following: (a) for a rose bengal test EUR 0,24 per test; (b) for a complement fixation test EUR 0,48 per test; ; Article 4 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 420 000 for Belgium; EUR 10 000 for Bulgaria; EUR 1 700 000 for the Czech Republic; EUR 0 for Denmark; EUR 400 000 for Germany; EUR 10 000 for Estonia; EUR 10 000 for Ireland; EUR 100 000 for Greece; EUR 5 200 000 for Spain; EUR 3 000 000 for France; EUR 300 000 for Italy; EUR 20 000 for Latvia; EUR 5 000 for Lithuania; EUR 60 000 for Hungary; EUR 10 000 for Malta; EUR 50 000 for the Netherlands; EUR 160 000 for Austria; EUR 50 000 for Poland; EUR 1 650 000 for Portugal; EUR 100 000 for Romania; EUR 50 000 for Slovenia; EUR 60 000 for Slovakia; EUR 20 000 for Finland; EUR 20 000 for Sweden. ; in paragraph 3, points (a) to (f) are replaced by the following: (a) for an ELISA test EUR 3 per test; (b) for a PCR test EUR 12 per test; (c) for the purchase of monovalent vaccines EUR 0,36 per dose; (d) for the purchase of bivalent vaccines EUR 0,54 per dose; (e) for the administration of vaccines to bovine animals EUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used; (f) for the administration of vaccines to ovine or caprine animals EUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used. ; Article 5 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 1 200 000 for Belgium; EUR 25 000 for Bulgaria; EUR 2 100 000 for the Czech Republic; EUR 340 000 for Denmark; EUR 1 000 000 for Germany; EUR 40 000 for Estonia; EUR 120 000 for Ireland; EUR 1 000 000 for Greece; EUR 1 300 000 for Spain; EUR 660 000 for France; EUR 1 700 000 for Italy; EUR 150 000 for Cyprus; EUR 1 650 000 for Latvia; EUR 20 000 for Luxembourg; EUR 2 400 000 for Hungary; EUR 150 000 for Malta; EUR 3 900 000 for the Netherlands; EUR 1 200 000 for Austria; EUR 4 800 000 for Poland; EUR 65 000 for Portugal; EUR 500 000 for Romania; EUR 120 000 for Slovenia; EUR 600 000 for Slovakia; EUR 75 000 for the United Kingdom. ; in paragraph 3, points (a) to (e) are replaced by the following: (a) for a bacteriological test (cultivation/isolation) EUR 8,4 per test; (b) for the purchase of vaccine EUR 0,06 per dose; (c) for serotyping of relevant isolates of Salmonella spp. EUR 24 per test; (d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock EUR 6 per test; (e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella EUR 6 per test. ; Article 6 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 120 000 for Bulgaria; EUR 1 600 000 for Germany; EUR 240 000 for France; EUR 160 000 for Italy; EUR 700 000 for Hungary; EUR 700 000 for Romania; EUR 30 000 for Slovenia; EUR 300 000 for Slovakia. ; in paragraph 3, ‘EUR 2,5’ is replaced by ‘EUR 3’; Article 8 is amended as follows: in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; paragraph 2(c) is replaced by the following: shall not exceed the following: EUR 90 000 for Belgium; EUR 25 000 for Bulgaria; EUR 70 000 for the Czech Republic; EUR 80 000 for Denmark; EUR 300 000 for Germany; EUR 10 000 for Estonia; EUR 75 000 for Ireland; EUR 50 000 for Greece; EUR 150 000 for Spain; EUR 150 000 for France; EUR 1 000 000 for Italy; EUR 20 000 for Cyprus; EUR 45 000 for Latvia; EUR 10 000 for Lithuania; EUR 10 000 for Luxembourg; EUR 360 000 for Hungary EUR 20 000 for Malta; EUR 360 000 for the Netherlands; EUR 60 000 for Austria; EUR 100 000 for Poland; EUR 45 000 for Portugal; EUR 180 000 for Romania; EUR 50 000 for Slovenia; EUR 15 000 for Slovakia; EUR 25 000 for Finland; EUR 50 000 for Sweden; EUR 160 000 for the United Kingdom. ; in paragraph 3, points (a) to (e) are replaced by the following: (a) ELISA test EUR 2,4 per test; (b) agar gel immune diffusion test EUR 1,44 per test; (c) HI test for H5/H7 EUR 14,40 per test; (d) virus isolation test EUR 48 per test; (e) PCR test EUR 24 per test. ; Article 9 is amended as follows: in paragraph 2(c), ‘50 %’ is replaced by ‘60 %’; paragraph 2(d) is replaced by the following: shall not exceed the following: EUR 1 900 000 for Belgium; EUR 330 000 for Bulgaria; EUR 1 030 000 for the Czech Republic; EUR 1 370 000 for Denmark; EUR 7 750 000 for Germany; EUR 330 000 for Estonia; EUR 4 000 000 for Ireland; EUR 2 000 000 for Greece; EUR 6 650 000 for Spain; EUR 18 850 000 for France; EUR 6 000 000 for Italy; EUR 1 700 000 for Cyprus; EUR 320 000 for Latvia; EUR 720 000 for Lithuania; EUR 125 000 for Luxembourg; EUR 1 180 000 for Hungary; EUR 25 000 for Malta; EUR 3 530 000 for the Netherlands; EUR 1 800 000 for Austria; EUR 3 440 000 for Poland; EUR 1 800 000 for Portugal; EUR 1 000 000 for Romania; EUR 250 000 for Slovenia; EUR 550 000 for Slovakia; EUR 580 000 for Finland; EUR 850 000 for Sweden; EUR 6 500 000 for the United Kingdom. ; in paragraph 3(d) ‘EUR 10’ is replaced by ‘EUR 12’; Article 10, paragraph 2(c) is amended as follows: in point (i) ‘EUR 1 800 000’ is replaced by ‘EUR 850 000’; in point (ii) ‘EUR 620 000’ is replaced by ‘EUR 570 000’; in point (iv) ‘EUR 7 110 000’ is replaced by ‘EUR 8 110 000’; in point (v) ‘EUR 5 000 000’ is replaced by ‘EUR 2 100 000’; in point (vii) ‘EUR 200 000’ is replaced by ‘EUR 290 000’; in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’; Article 11, paragraph 5(c) is amended as follows: in point (i) ‘EUR 2 250 000’ is replaced by ‘EUR 1 600 000’; in point (ii) ‘EUR 1 800 000’ is replaced by ‘EUR 1 500 000’; in point (v) ‘EUR 740 000’ is replaced by ‘EUR 850 000’; in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.